Work

Senescent T cells: a potential biomarker and target for cancer therapy

Year: 2021
Type: review
Abstract: The failure of T cells to eradicate tumour cells in the tumour microenvironment is mainly due to the dysfunction of T cells. Senescent T cells, with defects in proliferation and effector functions, accumulate in ageing, chronic viral infections, and autoimmune disorders where antigen stimulation persists. Increasing evidence suggests that inducing T cell senescence is a key strategy used by malignant tumours to evade immune surveillance. In this review, we summarize the general features, functional regulation, and signalling network of senescent T cells in tumour development and highlight their potential as prognostic biomarkers in multiple cancer treatments, including chemotherapy, radiotherapy, and immunotherapy. Moreover, we discuss possible therapeutic strategies for preventing or rejuvenating senescence in tumour-specific T cells. Understanding these critical issues may provide novel strategies to enhance cancer immunotherapy.
Source: EBioMedicine
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $3,500
OpenAlex ID: W3165767906
FWCI: 2.555
Cites: 103
Cited by: 188
Related to: 10